RECRUITING

Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.

Official Title

Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following

Quick Facts

Study Start:2024-10-23
Study Completion:2030-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06220721

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Hypertensive disorders of pregnancy (HDP) diagnosis, specifically gestational hypertension or preeclampsia, according to ACOG guidelines
  2. * Postpartum day 0-4
  3. * Able to communicate in English or in Spanish
  4. * Has an established OBGYN at an MCW or NU health system practice that has access to Epic electronic medical records.
  1. * Pre-gestational hypertension
  2. * Type 1 or type 2 diabetes mellitus
  3. * Admitted to intensive care unit at the time of screening
  4. * Diagnosed with HDP during postpartum readmission after discharge from delivery hospitalization
  5. * Getting discharged on the day of screening
  6. * Known allergy or contraindication to nifedipine ER
  7. * Inability or unwillingness to provide informed consent

Contacts and Locations

Study Contact

Alyssa M Hernandez, DO
CONTACT
4148055285
alyhernandez@mcw.edu
Amandla Stanley, MSN
CONTACT
4148056691
akstanley@mcw.edu

Principal Investigator

Anna Palatnik, MD
PRINCIPAL_INVESTIGATOR
Medical College of Wisconsin

Study Locations (Sites)

Northwestern University
Chicago, Illinois, 60611
United States
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
United States

Collaborators and Investigators

Sponsor: Medical College of Wisconsin

  • Anna Palatnik, MD, PRINCIPAL_INVESTIGATOR, Medical College of Wisconsin

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-23
Study Completion Date2030-06-30

Study Record Updates

Study Start Date2024-10-23
Study Completion Date2030-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Hypertension, Pregnancy-Induced